Fig. 1.
The representative for immnophenotype of BM-MSCs of healthy controls (n = 11) and AA patients (n = 15). The immnophenotype of BM-MSCs was assessed with monoclonal antibodies CD45, HLA-DR (HLA-II), CD90, CD34, CD29, CD166, CD105, CD44, CD73 and CD49e using a FACScan flow cytometry. All independent experiments were performed three times. Abbreviation: AA, aplastic anemia.